Latest filing published 16 May 2025 for Exelixis, INC., €331k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Amy C. Peterson: trading record in brief
Amy C. Peterson, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in BeOne Medicines Ltd., Exelixis, Inc. and CytomX Therapeutics, Inc. Over a trading history stretching from 22 August 2016 to 16 May 2025, the count stands at 60 filings.
The open-market record consists of 41 sales worth €10.7M, with no purchase. Outside the open market, there are 13 share grants and 6 option exercises. In 2025 alone, the filings show no purchases and 1 sale.
Most recently, on 16 May 2025, the filings show an option exercise worth €777k in Exelixis, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Amy C. Peterson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,303 shares@ US$44.6526.8% of flowCommon StockSEC:0000939767-25-000076:0
- 159,383 shares0Common StockSEC:0000939767-25-000055:0
- 52,192 shares0Common StockSEC:0000939767-25-000040:0
- 27,224 shares@ US$35.0573.2% of flowCommon StockSEC:0000939767-24-000158:0
- 82,121 shares0Common StockSEC:0000939767-24-000035:0
- 240,000 shares0Common StockSEC:0000939767-23-000098:0
- 4,257 shares@ US$1.97919.4% of flowCommon StockSEC:0001140361-23-012614:0
- 20,000 shares0Common StockSEC:0001567619-22-014301:0
- 40,000 shares0Common StockSEC:0001567619-22-002525:0
- 3,320 shares@ US$6.08667.5% of flowCommon StockSEC:0001567619-21-011806:0
10 of 10 declarations
